Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: Children watch television in the living room of an apartment that is for sale for $4.5 million in New York in this January 13, 2011 file photo. REUTERS/Lucas Jackson This type of disguised advertising, including high exposure to sugary soft drinks on prime-time TV, is a major contributing factor to childhood obesity, according to the Yale University study released Tuesday. “It is a very subtle message that kids aren’t likely to get,” said Jennifer Harris, a co-author of the study and director of marketing initiatives at Yale’s Rudd Center for Food Policy and Obesity. The Yale study aimed to quantify how many product placements appear on prime-time TV and also determine how many of those that kids actually see. Researchers analyzed Nielsen media data from 2008 and found some 35,000 brand placements had appeared on prime-time television that year. Children tend to see about 14 traditional advertisements for food and beverages each day on television compared to one of these product placements, it said. But children don’t yet have the cognitive ability to understand that the popular soda, candy and snack brands they see on prime-time shows are a means of advertising. “It is even more difficult for younger children to understand this is advertising and that it is persuading them to do something that isn’t the best thing for them,” Harris said. Despite most major food companies pledging not to pay for unhealthy food ads in children’s programing, brand appearances in prime-time shows and sportscasts viewed by a wide audience, including kids, is exposing them to these products anyway, Harris said. Harris said Coca-Cola product placements on popular talent show American Idol was the most viewed brand. Children saw five times as many product placements as they did traditional, paid television commercials for Coca-Cola products. Roughly one-third of children in the United States are overweight or obese, said Harris. Drinking sugar-sweetened beverages puts kids at greater risk for obesity, but also long-term health problems like diabetes, heart disease and high blood pressure, she said. The study will appear in the September issue of the American Journal of Preventive Medicine. Claim: TV product placements termed junk food ad loophole.
[EX A]: Companies that have pledged not to market unhealthy food and drinks directly to children may be turning to product placement on television shows instead of traditional ads to target youngsters, a new study showed.

[EX Q]: Paragraph: But within the holding pattern there is a dramatic rise in “extreme” obesity among adults and children. The annual “F as in Fat” report from the Trust for America’s Health and the Robert Wood Johnson Foundation found that the proportion of adults who are extremely obese - at least 100 pounds (45.4 kilograms) overweight - has climbed over the last three decades from 1.4 percent in the late 1970s to 6.3 percent in 2009-2010. That is about a 350 percent increase, researchers for the health nonprofit groups said. About 5 percent of children and teenagers are also now severely obese, they added. Rates of extreme obesity were nearly twice as high for women as for men, and were also particularly high for Hispanic boys and black girls. “As long as we continue to see those increases in extreme obesity, I think we need to be worried,” Trust for America’s Health Executive Director Jeffrey Levi told Reuters. Overall, the report found obesity rates stabilizing across the United States, though at historically high levels with nearly 36 percent of U.S. adults obese as of 2010. Only one state, Arkansas, had an increase in obesity levels. The findings follow this month’s announcement that the obesity rate among low-income children between the ages of 2 and 4 dropped slightly, after 30 years of increases. “After decades of bad news, we’re finally seeing signs of progress,” researchers for the two health groups wrote in Friday’s report that said government efforts to encourage healthier diets and more exercise were paying off. “I’m delighted but not surprised,” said Kelly Brownell, dean of Sanford School of Public Policy at Duke University. “The collective effect is having an impact and turning things around ... We’ve managed the plateau, we may remain there. We will have to do more to achieve a downturn.”  The analysis, based on data from the Centers for Disease Control and Prevention, underscored America’s continuing battle with weight. Obesity rates were highest in the South and Midwest in states including Louisiana, Mississippi and Oklahoma. In addition to geographic differences, rates were higher for people with less education and lower incomes, it found. Rates for those ages 45 to 64, the bulk of the so-called Baby Boomer generation, were also a concern as their obesity rates were 30 percent or higher in 41 states. In Alabama and Louisiana, their rate reached 40 percent. Increasingly heavy men also narrowed the obesity gender gap. “Ten years ago, the obesity rate for women was significantly higher than the rate for men,” 33.4 percent compared to 27.5 percent, researchers wrote. Now, their “rates are essentially the same” at nearly 36 percent, they said. Health experts agreed with the report’s conclusion that various government programs making school lunches healthier, mandating calorie counts on menus, discouraging soda consumption, integrating physical activity into the daily life and other weight-conscious changes were adding up to widespread behavior changes. The report recommended strengthening such programs. It said food and beverage companies should market only their healthiest products to children, the nation’s transportation plans should encourage walking and biking, and everyone should be able to buy healthy, affordable foods close to home. Obesity is commonly measured by body mass index (BMI), a measure of one’s height to weight. A BMI score of 30 or more is defined as obese, while extreme obesity is a score of 40 or higher. A score of 25 to 29 is considered overweight. Claim: U.S. obesity leveling off, but at high rate: report.
[EX A]: Obesity levels among adults appear to be holding steady across the United States, adding to recent evidence that the growth rate for U.S. waistlines is slowing, according to an analysis released on Friday.

[EX Q]: Paragraph: The U.S. Food and Drug Administration’s partial hold on the so-called STRONG trial impacts patients aged up to five with spinal muscular atrophy (SMA) who were to receive a higher dose of the gene therapy via a spinal infusion. The hold was issued after Novartis told health authorities about the animal study’s findings that showed dorsal root ganglia (DRG) mononuclear cell inflammation, a neurological condition sometimes accompanied by nerve damage or loss. Novartis shares fell 1% at 0715 GMT, while other European drugmakers rose. Analysts said more information was needed to assess whether these findings could have an impact on Zolgensma’s long-term prospects. “We need to better understand, what the issues are and whether there really is a read-through to the human trial,” Vontobel analyst Stefan Schneider said. Novartis said it was working with regulators, in hopes of having the hold released. Zolgensma, whose $2.1 million list price makes it the world’s most-expensive treatment, is already approved for children aged up to two with the deadly muscle wasting disease and is given by infusion into the young patients’ veins. The medicine had $160 million in sales in its first full quarter on the market. The STRONG study is meant to underpin its expanded approval for older children, where Novartis would also compete with Biogen’s Spinraza that is already on the market, and Roche’s investigational risdiplam that is due to seek approval this year. Roche shares were up 0.7%. “The clinical significance of the DRG inflammation observed in this pre-clinical animal study is not known and was not seen in prior animal studies,” Novartis said in a statement. “We are working with health authorities to confirm further guidance to clinical investigators.”  The partial FDA hold halts enrollment of patients getting a higher dose of Zolgensma, also known as AVXS-101, via an spinal infusion, also called intrathecal administration. Low- and mid-dose portions of the STRONG trial have already been completed, as has presentation of interim results. “Of note, we have completed a thorough review of human safety data from all available sources to date and no adverse effects related to sensory changes have been seen,” Novartis said. Claim: Novartis' Zolgensma study halted by FDA amid safety questions.
[EX A]:
U.S. regulators have halted a trial of Novartis’s Zolgensma treatment after an animal study raised safety concerns, the company said on Wednesday, in a setback for the drugmaker’s plan to expand its use to older patients.